Clinical Trial Update: Bictegravir/Emtricitabine/Tenofovir Alafenide Plus Doravirine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial of a bictegravir/emtricitabine/tenofovir alafenamide plus doravirine regimen for HIV-1 infection has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Bictegravir/Emtricitabine/Tenofovir Alafenamide (Bictegravir/emtricitabine/tenofovir alafenamide)
• Doravirine (doravirine)

Snippet

Sponsor: Quest Clinical Research | Conditions: HIV-1-infection | Phase 4 | Status: COMPLETED | Results posted: 2024-03-05